HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
PDF Library
RSS Feeds
Subscribe
FAQs
Advertising
Partnered Content
Report Store
UsernamePublicRestriction
Tags:
United Kingdom Health Brexit

EU OTC Batch Testing Will Continue To Be Accepted In UK, For Now

  • News

Executive Summary

Recognition of EU/EEA batch testing of imported medicines by UK will not be ending on 1 January 2023, and companies will be given two years notice if anything changes, says MHRA.

You may also be interested in...



How The UK Self-Care Industry Coped With COVID-19 And Brexit in 2020

PAGB CEO Michelle Riddalls tells HBW Insight what it was like to lead the UK consumer health industry during 2020 in the middle of Brexit and COVID-19.

UK Consumer Health Industry ‘Relieved’ By Post-Brexit Deal

UK consumer health industry association PAGB says it is "relieved" a last minute post-Brexit deal has been struck, which will enable its members to continue to supply OTCs to the EU with limited disruption. 

LanesHealth Alert To Cognitive Health And Naturals Trends With UK Supplement Launches

LanesHealth's UK supplement brands Pro Plus and Gopo get on-trend line extenstions in the areas of cognitive health and natural medicinal alternatives. 

Table

View full table

Topics

Tags:
United Kingdom Health Brexit
UsernamePublicRestriction

Register

RS151133

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By